Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters. Authors' reply
- PMID: 35429035
- PMCID: PMC9111210
- DOI: 10.1111/apt.16904
Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters. Authors' reply
Abstract
This article is linked to Kokkotis et al papers. To view these articles, visit
Comment on
-
Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments.Aliment Pharmacol Ther. 2022 Jan;55(2):154-167. doi: 10.1111/apt.16717. Epub 2021 Dec 8. Aliment Pharmacol Ther. 2022. PMID: 34881430
-
Letter: COVID-19 outcomes and anti-TNF treatments-comprehensive evidence matters.Aliment Pharmacol Ther. 2022 May;55(9):1233-1234. doi: 10.1111/apt.16872. Aliment Pharmacol Ther. 2022. PMID: 35429022 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical